COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

• 收藏
• 分享

专利权人:

LES LABORATOIRES SERVIER;NOVARTIS AG

发明人:

WEI, Andrew,MOUJALLED, Donia,POMILIO, Giovanna,GENESTE, Olivier,MARAGNO, Ana-Leticia

申请号：

SG11201911891W

公开号：

SG11201911891WA

申请日:

2018.06.21

申请国别(地区):

SG

年份:

2020

代理人:

摘要：

A combination comprising a Mcl-1 inhibitor and a second anticancer agent, wherein the second anticancer agent is selected from anthracyclines, cytarabine and hypomethylating agents, and compositions and uses thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/